Attached files
| file | filename |
|---|---|
| EX-10.1 - VIVOS INC | ex10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2021
VIVOS INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-53497 | 80-0138937 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 719 Jadwin Avenue, Richland, WA | 99352 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (509) 736-4000
| N/A |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 1.01 Entry into a Material Definitive Agreement
See Item 5.02 below.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 3, 2021, Vivos Inc. (the “Company”) entered into an amended employment agreement with Michael K. Korenko, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, deemed effective January 1, 2021 (the “Korenko Amendment”). A copy of the Korenko Amendment is attached hereto as Exhibit 10.1.
Item 9.01 Financial Statements and Exhibits.
Se exhibit index.
Exhibit Index
| Exhibit No. | Description | |
| 10.1 | Employment Agreement between the Company and Mr. Korenko, dated May 3, 2021. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: May 7, 2021 | VIVOS INC. | |
| By: | /s/ Michael Korenko | |
| Name: | Michael Korenko | |
| Title: | Chief Executive Officer | |